Back to Authors

Hisamatsu, T.

Mayo Clinic

Kyorin University

Citations 1

Efficacy of Mirikizumab in Comparison to Ustekinumab in Patients With Moderate-to-Severe Crohn’s Disease: Results From the Phase 3 VIVID-1 Study
Ferrante, M., Kaser, Arthur , Reinisch, Walter, Bragg, S. M., Lin, Zhantao, Lopes, Michelle Ugolini, Protić, Marijana , Jairath, Vipul , Sands, Bruce E , Bossuyt, Peter , Farraye, Francis A. , Hisamatsu, T., Kierkuś, Jarosław , Laharie, David , Siegmund, Britta , Hon, Kam‐Lun Ellis , Morris, Nathan , Danese, Silvio

Zeitschrift für Gastroenterologie | November 27, 2025 | Volume: 62 | Issue: 05 | Pages: e481-e482

10.1055/s-0044-1786891 Get It